FDA warned rxshopmd.com, a Cyprus website, for selling unapproved and misbranded drugs, including lopinavir/ritonavir, to U.S. consumers online.
What happened
FDA reviewed www.rxshopmd.com on December 13, 2021, and found it offered drug products for sale in the U.S. intended to treat COVID-19 and other diseases such as HIV. The site offered, for example, Hivus-LR (lopinavir + ritonavir 200/50 mg) made by Aurobindo Pharma Ltd., which has no FDA-approved application, was described as approved for COVID-19, and was offered without requiring a prescription.
What FDA found
The website sells drugs that FDA has not approved for sale in the U.S.
section 505(a) of the FD&C Act [21 U.S.C. § 355(a)]The prescription drug labeling does not give adequate directions for safe use by a layperson.
section 502(f)(1) of the FD&C Act [21 U.S.C. § 352(f)(1)]; 21 CFR 201.115(a)The website offers prescription drugs without requiring a prescription.
section 503(b)(1) of the FD&C Act [21 U.S.C. § 353(b)(1)]; section 301(k) [21 U.S.C. § 331(k)]The website claims lopinavir/ritonavir is approved for COVID-19 when FDA has not approved that use.
section 502 of the FD&C Act [21 U.S.C. § 352]
What FDA wants
FDA asks rxshopmd.com to email two FDA task forces within 48 hours to describe the specific steps taken to address the violations and prevent recurrence, including related documents. If corrective action cannot be completed in 48 hours, FDA asks for the reason for delay and the time by which it will be completed.
Who should pay attention
- U.S. consumers who buy prescription drugs from foreign websites
- online pharmacies selling to U.S. consumers
- drugmakers whose products are listed on unapproved online pharmacy sites
This is a summary. Read the original letter on fda.gov.